Complete remission after myeloablation with bone-seeking 186Re-HEDP and high-dose melphalan followed by autologous stem cell transplantation in a patient with chemorefractory multiple myeloma. [electronic resource]
- Bone marrow transplantation Jul 2005
- 89-90 p. digital
Publication Type: Case Reports; Letter
0268-3369
10.1038/sj.bmt.1705002 doi
Bone and Bones--metabolism Disease-Free Survival Etidronic Acid--pharmacokinetics Humans Melphalan--therapeutic use Middle Aged Multiple Myeloma--therapy Myeloablative Agonists--therapeutic use Organometallic Compounds--pharmacokinetics Peripheral Blood Stem Cell Transplantation--methods Radioisotopes--therapeutic use Remission Induction--methods Rhenium--therapeutic use Salvage Therapy--methods Transplantation, Autologous